Literature DB >> 25894846

Racial/ethnic and socioeconomic disparities in survival among children with acute lymphoblastic leukemia in California, 1988-2011: A population-based observational study.

Renata Abrahão1,2, Daphne Y Lichtensztajn2, Raul C Ribeiro3, Neyssa M Marina4, Ruth H Keogh5, Rafael Marcos-Gragera6, Sally L Glaser2,7, Theresa H M Keegan2,7.   

Abstract

BACKGROUND: Despite advances in treatment, survival from acute lymphoblastic leukemia (ALL) remains lower among non-White children than White children in the US. We investigated the association of race/ethnicity and socioeconomic status (SES) with survival. PROCEDURES: We analyzed 9,295 Californian children (3,251 Whites, 4,890 Hispanics, 796 Asians, and 358 Blacks) aged ≤ 19 years diagnosed with a first primary ALL during 1988-2011. We used the Kaplan-Meier method to estimate survival at 1, 5, and 10 years after diagnosis for three calendar periods. Hazard ratios of death for race/ethnicity, SES, and clinical factors were estimated by Cox regression models.
RESULTS: Median follow-up time was 7.4 years (range 0-25 years). Over time, survival after ALL improved steadily, but inequalities persisted across races/ethnicities. Five-year survival (95% confidence interval) was 85.0% (83.6-86.2) for White, 81.4% (78.3-84.0) for Asian, 79.0% (77.8-80.2) for Hispanic, and 74.4% (69.4-78.8) for Black children. In multivariable-adjusted models, the hazard of death was increased by 57% among Black, 38% among Hispanic, and 33% among Asian children compared with White children. Patients residing in the lowest SES neighborhoods at diagnosis had a 39% increased risk of death relative to those living in higher SES neighborhoods.
CONCLUSION: Despite significant improvements in survival, non-White children and children residing in low SES neighborhoods experienced worse survival even after adjusting for potential confounders. Our findings highlight the need to capture specific information on disease biology, treatment, and treatment adherence to better understand the predictors of lower survival in minority and low SES groups.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  SES; childhood; leukemia; population-based; race/ethnicity; survival

Mesh:

Year:  2015        PMID: 25894846      PMCID: PMC9458416          DOI: 10.1002/pbc.25544

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.838


  30 in total

1.  Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: evidence from the SEER database 1988-2008.

Authors:  William B Goggins; Fiona F K Lo
Journal:  Cancer Causes Control       Date:  2012-03-27       Impact factor: 2.506

2.  Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia.

Authors:  Nobuko Hijiya; Melissa M Hudson; Shelly Lensing; Margie Zacher; Mihaela Onciu; Fred G Behm; Bassem I Razzouk; Raul C Ribeiro; Jeffrey E Rubnitz; John T Sandlund; Gaston K Rivera; William E Evans; Mary V Relling; Ching-Hon Pui
Journal:  JAMA       Date:  2007-03-21       Impact factor: 56.272

3.  Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study.

Authors:  Eva Steliarova-Foucher; Charles Stiller; Peter Kaatsch; Franco Berrino; Jan-Willem Coebergh; Brigitte Lacour; Max Parkin
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

4.  Trends in leukemia incidence and survival in the United States (1973-1998).

Authors:  Yang Xie; Stella M Davies; Ying Xiang; Leslie L Robison; Julie A Ross
Journal:  Cancer       Date:  2003-05-01       Impact factor: 6.860

5.  Racial and ethnic differences in survival of children with acute lymphoblastic leukemia.

Authors:  Smita Bhatia; Harland N Sather; Nyla A Heerema; Michael E Trigg; Paul S Gaynon; Leslie L Robison
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

6.  Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia.

Authors:  N J Bunin; C H Pui
Journal:  J Clin Oncol       Date:  1985-12       Impact factor: 44.544

7.  Survival in childhood acute lymphocytic leukemia: effect of protocol and place of treatment.

Authors:  A T Meadows; S Kramer; R Hopson; E Lustbader; P Jarrett; A E Evans
Journal:  Cancer Invest       Date:  1983       Impact factor: 2.176

8.  Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.

Authors:  Heng Xu; Wenjian Yang; Virginia Perez-Andreu; Meenakshi Devidas; Yiping Fan; Cheng Cheng; Deqing Pei; Paul Scheet; Esteban González Burchard; Celeste Eng; Scott Huntsman; Dara G Torgerson; Michael Dean; Naomi J Winick; Paul L Martin; Bruce M Camitta; W Paul Bowman; Cheryl L Willman; William L Carroll; Charles G Mullighan; Deepa Bhojwani; Stephen P Hunger; Ching-Hon Pui; William E Evans; Mary V Relling; Mignon L Loh; Jun J Yang
Journal:  J Natl Cancer Inst       Date:  2013-03-19       Impact factor: 13.506

9.  Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.

Authors:  C H Pui; D Pei; J T Sandlund; R C Ribeiro; J E Rubnitz; S C Raimondi; M Onciu; D Campana; L E Kun; S Jeha; C Cheng; S C Howard; M L Metzger; D Bhojwani; J R Downing; W E Evans; M V Relling
Journal:  Leukemia       Date:  2009-12-10       Impact factor: 11.528

10.  Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era.

Authors:  Li Tao; James M Foran; Christina A Clarke; Scarlett L Gomez; Theresa H M Keegan
Journal:  Blood       Date:  2014-04-04       Impact factor: 25.476

View more
  30 in total

Review 1.  Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.

Authors:  Rochelle R Maxwell; Peter D Cole
Journal:  Curr Hematol Malig Rep       Date:  2017-06       Impact factor: 3.952

2.  Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD-2 study.

Authors:  Eric W Tai; Kevin C Ward; Audrey Bonaventure; David A Siegel; Michel P Coleman
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

Review 3.  Disparities in Survival and Health Outcomes in Childhood Leukemia.

Authors:  Lena E Winestone; Richard Aplenc
Journal:  Curr Hematol Malig Rep       Date:  2019-06       Impact factor: 3.952

4.  An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001.

Authors:  Justine M Kahn; Peter D Cole; Traci M Blonquist; Kristen Stevenson; Zhezhen Jin; Sergio Barrera; Randy Davila; Emily Roberts; Donna S Neuberg; Uma H Athale; Luis A Clavell; Caroline Laverdiere; Jean-Marie Leclerc; Bruno Michon; Marshall A Schorin; Jennifer J G Welch; Stephen E Sallan; Lewis B Silverman; Kara M Kelly
Journal:  Pediatr Blood Cancer       Date:  2017-11-01       Impact factor: 3.167

5.  Socioeconomic Status, Race/Ethnicity, and Health Disparities in Children and Adolescents in a Mixed Rural-Urban Community-Olmsted County, Minnesota.

Authors:  Kara A Bjur; Chung-Il Wi; Euijung Ryu; Chris Derauf; Sheri S Crow; Katherine S King; Young J Juhn
Journal:  Mayo Clin Proc       Date:  2019-01       Impact factor: 7.616

6.  Payer and race/ethnicity influence length and cost of childhood cancer hospitalizations.

Authors:  Sarah B Whittle; Michelle A Lopez; Heidi V Russell
Journal:  Pediatr Blood Cancer       Date:  2019-04-16       Impact factor: 3.167

7.  Racial and ethnic differences in survival of pediatric patients with brain and central nervous system cancer in the United States.

Authors:  David A Siegel; Jun Li; Helen Ding; Simple D Singh; Jessica B King; Lori A Pollack
Journal:  Pediatr Blood Cancer       Date:  2018-10-23       Impact factor: 3.167

8.  The Association of Race With Childhood Uveitis.

Authors:  Sheila T Angeles-Han; Courtney McCracken; Steven Yeh; Kirsten Jenkins; Daneka Stryker; Curtis Travers; Kelly Rouster-Stevens; Larry B Vogler; Scott R Lambert; Carolyn Drews-Botsch; Sampath Prahalad
Journal:  Am J Ophthalmol       Date:  2015-08-06       Impact factor: 5.258

Review 9.  Scientific Achievements May Not Reach Everyone: Understanding Disparities in Acute Leukemia.

Authors:  Manali I Patel
Journal:  Curr Hematol Malig Rep       Date:  2016-08       Impact factor: 3.952

10.  Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.

Authors:  Justine M Kahn; Theresa H M Keegan; Li Tao; Renata Abrahão; Archie Bleyer; Aaron D Viny
Journal:  Cancer       Date:  2016-06-10       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.